Evolution of the stroke paradigm: A review of delayed recanalization

J Cereb Blood Flow Metab. 2021 May;41(5):945-957. doi: 10.1177/0271678X20978861. Epub 2020 Dec 16.

Abstract

While the time window for reperfusion after ischemic stroke continues to increase, many patients are not candidates for reperfusion under current guidelines that allow for reperfusion within 24 h after last known well time; however, many case studies report favorable outcomes beyond 24 h after symptom onset for both spontaneous and medically induced recanalization. Furthermore, modern imaging allows for identification of penumbra at extended time points, and reperfusion risk factors and complications are becoming better understood. Taken together, continued urgency exists to better understand the pathophysiologic mechanisms and ideal setting of delayed recanalization beyond 24 h after onset of ischemia.

Keywords: Delayed recanalization; Stroke; penumbra; perfusion; tPA.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Brain / blood supply*
  • Brain / diagnostic imaging
  • Brain / physiopathology
  • Cerebral Blood Volume / physiology
  • Cerebrovascular Circulation / physiology
  • Child
  • Combined Modality Therapy / methods
  • Diffusion Magnetic Resonance Imaging / methods
  • Diffusion Magnetic Resonance Imaging / statistics & numerical data
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Ischemic Stroke / diagnosis
  • Ischemic Stroke / physiopathology*
  • Ischemic Stroke / surgery
  • Magnetic Resonance Angiography / methods
  • Magnetic Resonance Angiography / statistics & numerical data
  • Male
  • Mechanical Thrombolysis / methods
  • Middle Aged
  • Reperfusion / adverse effects
  • Reperfusion / methods*
  • Risk Factors
  • Thrombolytic Therapy / methods
  • Time Factors
  • Time-to-Treatment / standards*
  • Time-to-Treatment / trends
  • Tissue Plasminogen Activator / therapeutic use
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator